Literature DB >> 34743247

Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.

Shefali Chopra1, Nolan Maloney2, Wei Lien Wang2.   

Abstract

Epithelioid inflammatory myofibroblastic sarcomas are an aggressive variant of inflammatory myofibroblastic tumor described primarily in the abdomen and less commonly in pulmonary location. The anaplastic lymphoma kinase (ALK) fusion partners described in this tumor include RANB2, RRBP1 and EML4. While rare examples of inflammatory myofibroblastic tumors have been described in the central nervous system, the epithelioid variant has never been described. The ALK-VCL fusion has been described in renal cell carcinoma, high-grade glioma and epithelioid fibrous histiocytoma but has not been described in epithelioid inflammatory myofibroblastic sarcoma or even inflammatory myofibroblastic tumor. Herein, we report the first case of epithelioid inflammatory myofibroblastic sarcoma in the central nervous system as well as the first case with VCL as the fusion partner for ALK.
© 2021. The Author(s), under exclusive licence to The Author(s) under exclusive licence to The Japan Society of Brain Tumor Pathology.

Entities:  

Keywords:  ALK–VCL fusion; Central nervous system; Epithelioid inflammatory myofibroblastic sarcoma

Mesh:

Substances:

Year:  2021        PMID: 34743247     DOI: 10.1007/s10014-021-00416-z

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  30 in total

1.  A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.

Authors:  Shiro Kimbara; Koji Takeda; Hiroko Fukushima; Toru Inoue; Hideaki Okada; Yumi Shibata; Utae Katsushima; Asuka Tsuya; Shinya Tokunaga; Haruko Daga; Takahiro Okuno; Takeshi Inoue
Journal:  Jpn J Clin Oncol       Date:  2014-07-15       Impact factor: 3.019

Review 2.  ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.

Authors:  Chien-Feng Li; Hsuan-Ying Huang; Mei-Jun Zhu; Jen-Chieh Lee; Adrián Mariño-Enríquez; Chung-Ta Lee; Wen-Bin Ou; Jason L Hornick; Jonathan A Fletcher
Journal:  J Pathol       Date:  2016-12-15       Impact factor: 7.996

3.  Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.

Authors:  Hong Fang; Carrie L Langstraat; Daniel W Visscher; Andrew L Folpe; J Kenneth Schoolmeester
Journal:  Int J Gynecol Pathol       Date:  2018-09       Impact factor: 2.762

4.  Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics.

Authors:  Pei Xu; Pingping Shen; Yangli Jin; Li Wang; Weiwei Wu
Journal:  Int J Clin Exp Pathol       Date:  2019-05-01

5.  Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.

Authors:  Adrián Mariño-Enríquez; Wei-Lien Wang; Angshumoy Roy; Dolores Lopez-Terrada; Alexander J F Lazar; Christopher D M Fletcher; Cheryl M Coffin; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2011-01       Impact factor: 6.394

6.  An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.

Authors:  Sung-Ting Chen; Jen-Chieh Lee
Journal:  Hum Pathol       Date:  2008-08-12       Impact factor: 3.466

7.  Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity.

Authors:  Yoshiki Kozu; Mitsuhiro Isaka; Yasuhisa Ohde; Kengo Takeuchi; Takashi Nakajima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-01-24

8.  Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor.

Authors:  J M Meis; F M Enzinger
Journal:  Am J Surg Pathol       Date:  1991-12       Impact factor: 6.394

9.  Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.

Authors:  Quan Jiang; Han-Xing Tong; Ying-Yong Hou; Yong Zhang; Jing-Lei Li; Yu-Hong Zhou; Jing Xu; Jiong-Yuan Wang; Wei-Qi Lu
Journal:  Orphanet J Rare Dis       Date:  2017-05-23       Impact factor: 4.123

Review 10.  Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.

Authors:  Lin Yu; Jinguo Liu; I Weng Lao; Zhiguo Luo; Jian Wang
Journal:  Diagn Pathol       Date:  2016-07-27       Impact factor: 2.644

View more
  1 in total

Review 1.  Inflammatory Myofibroblastic Tumour: State of the Art.

Authors:  Louis Gros; Angelo Paolo Dei Tos; Robin L Jones; Antonia Digklia
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.